Abnormal α-synuclein interactions with rab proteins in α-synuclein A30P transgenic mice

被引:79
|
作者
Dalfó, E
Gómez-Isla, T
Rosa, JL
Bodelón, MN
Tejedor, MC
Barrachina, M
Ambrosio, S
Ferrer, I
机构
[1] Hosp Univ Bellvitge, Serv Anat Patol, Inst Neuropatol, Hosp Llobregat, Barcelona 08907, Spain
[2] Univ Barcelona, Dept Biol Cellular & Anat Patol, Unitat Neuropatol Expt, Barcelona, Spain
[3] Univ Barcelona, Hosp Llobregat, Dept Ciencias Fisiol 2, Unitat Bioquim, Barcelona, Spain
[4] Univ Navarra, Dept Neurol, Navarra, Spain
关键词
alpha-synuclein; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); Parkinson disease; Rab3a; Rab5; Rab8; rotenone;
D O I
10.1093/jnen/63.4.302
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutation A30P in the a-synuclein gene is a cause of familial Parkinson disease. Transgenic mice expressing wild mouse and mutant human A30P alpha-synuclein, Tg5093 mice (Tg), show a progressive motor disorder characterized by tremor, rigidity, and dystonia, accompanied by accumulation of alpha-synuclein in the soma and neurites and by a conspicuous gliosis beginning in the hippocampal formation at the age of 7 to 8 months and spreading throughout the CNS. Impaired short-term changes in synaptic strength have also been documented in hippocampal slices from Tg mice. alpha-synuclein aggregates of approximately 34 and 70 kDa, in addition to the band of 17 kDa, corresponding to the molecular weight of a-synuclein, were recovered in the PBS-soluble fraction of brain homogenates from Tg mice but not from brain samples from age-matched wildtype littermates. MPTP-treated Tg and wildtype mice produced alpha-synuclein aggregates in the PBS-, deoxycholate-, and SDS-soluble fractions. Aggregates of alpha-synuclein, although with different molecular weights, were also observed in rotenone-treated Tg and wildtype mice. Pull-down studies with members of the Rab protein family have shown that a-synuclein from Tg mice interacts with Rab3a, Rab5, and Rab8. This binding is not due to the amount of alpha-synuclein (levels of which are higher in Tg mice) and it is not dependent on the amount of Rab protein used in the assay. Rather, alpha-synuclein interactions with Rab proteins are due to mutant (x-synuclein as demonstrated in Rab pull-down assays with recombinant of wildtype and mutant A30P human alpha-synuctein. Since Rab3a, Rab5, and Rab8 are important proteins involved in synaptic vesicle trafficking and exocytosis at the synapse, vesicle endocytosis, and trans-Golgi transport, respectively, it can be suggested that these functions are impaired in Tg mice. This rationale is consistent with previous data showing that short-term hippocampal synaptic plasticity is altered and that a.-synuclein accumulates in the cytoplasm of neurons in Tg mice.
引用
收藏
页码:302 / 313
页数:12
相关论文
共 50 条
  • [1] Behavioral changes in transgenic A30P α-synuclein mutation mice
    Oksman, M
    Puoliväli, J
    Jäkälä, P
    Tanita, H
    Beyreuther, K
    Hartmann, T
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S244 - S244
  • [2] Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α-synuclein knockout and A30P transgenic mice
    Yavich, Leonid
    Jakala, Pekka
    Tanila, Heikki
    JOURNAL OF NEUROCHEMISTRY, 2006, 99 (03) : 724 - 732
  • [3] Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice
    Nieto, María
    Gil-Bea, Francisco J.
    Dalfó, Esther
    Cuadrado, Mar
    Cabodevilla, Felipe
    Sanchez, Belén
    Catena, Silvia
    Sesma, Teresa
    Ribe, Elena
    Ferrer, Isidro
    Ramirez, María J.
    Gomez-Isla, Teresa
    NEUROBIOLOGY OF AGING, 2006, 27 (06) : 848 - 856
  • [4] Investigation of [A30P]α-synuclein transgenic mice in tests of motor performance and cognition
    Freichel, CP
    Ozmen, L
    Kahle, PJ
    Ballard, TM
    Spooren, W
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S36 - S36
  • [5] Intracellular α-synuclein (α-syn) accumulation in transgenic mice expressing A30P α-syn mutation
    Jakala, P
    Puolivali, J
    Kerokoski, P
    van Groen, T
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S252 - S252
  • [6] Behavioural and neurochemical response of α-synuclein A30P transgenic mice to the effects of L-DOPA
    Oksman, Mari
    Tanila, Heikki
    Yavich, Leonid
    NEUROPHARMACOLOGY, 2009, 56 (03) : 647 - 652
  • [7] Motor dysfunction and gliosis with preserved dopaminergic markers in human α-synuclein A30P transgenic mice
    Gomez-Isla, T
    Irizarry, MC
    Mariash, A
    Cheung, B
    Soto, O
    Schrump, S
    Sondel, J
    Kotilinek, L
    Day, J
    Schwarzschild, MA
    Cha, JHJ
    Newell, K
    Miller, DW
    Uéda, K
    Young, AB
    Hyman, BT
    Ashe, KH
    NEUROBIOLOGY OF AGING, 2003, 24 (02) : 245 - 258
  • [8] MicroRNA and proteome expression profiling in early-symptomatic α-synuclein(A30P)-transgenic mice
    Gillardon, Frank
    Mack, Matthias
    Rist, Wolfgang
    Schnack, Cathrin
    Lenter, Martin
    Hildebrandt, Tobias
    Hengerer, Bastian
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (05) : 697 - 705
  • [9] Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein
    Frasier, M
    Walzer, M
    McCarthy, L
    Magnuson, D
    Lee, JM
    Haas, C
    Kahle, P
    Wolozin, B
    EXPERIMENTAL NEUROLOGY, 2005, 192 (02) : 274 - 287
  • [10] Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice -: a model of familial Parkinson's disease
    Poon, HF
    Frasier, M
    Shreve, N
    Calabrese, V
    Wolozin, B
    Butterfield, DA
    NEUROBIOLOGY OF DISEASE, 2005, 18 (03) : 492 - 498